BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 7623373)

  • 1. Effect of low energy diet and weight loss on major risk factors, central obesity and associated disturbances in patients with essential hypertension.
    Singh RB; Niaz MA; Bishnoi I; Singh U; Begum R; Rastogi SS
    J Hum Hypertens; 1995 May; 9(5):355-62. PubMed ID: 7623373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can guava fruit intake decrease blood pressure and blood lipids?
    Singh RB; Rastogi SS; Singh NK; Ghosh S; Gupta S; Niaz MA
    J Hum Hypertens; 1993 Feb; 7(1):33-8. PubMed ID: 8383769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in glycaemic status do not predict weight loss in response to hypocaloric diets in obese patients.
    de Luis DA; Aller R; Izaola O; Gonzalez Sagrado M; Conde R
    Clin Nutr; 2006 Feb; 25(1):117-22. PubMed ID: 16278036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of diet and weight reduction in hypertension.
    Singh RB; Rastogi SS; Mehta PJ; Mody R; Garg V
    Nutrition; 1990; 6(4):297-302. PubMed ID: 2134545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of sibutramine for weight loss in obese patients with hypertension well controlled by beta-adrenergic blocking agents: a placebo-controlled, double-blind, randomised trial.
    Sramek JJ; Leibowitz MT; Weinstein SP; Rowe ED; Mendel CM; Levy B; McMahon FG; Mullican WS; Toth PD; Cutler NR
    J Hum Hypertens; 2002 Jan; 16(1):13-9. PubMed ID: 11840225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
    Sasaki J; Ikeda Y; Kuribayashi T; Kajiwara K; Biro S; Yamamoto K; Ageta M; Kobori S; Saikawa T; Otonari T; Kono S
    Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of orlistat on cardiovascular disease risk in obese adults.
    Swinburn BA; Carey D; Hills AP; Hooper M; Marks S; Proietto J; Strauss BJ; Sullivan D; Welborn TA; Caterson ID
    Diabetes Obes Metab; 2005 May; 7(3):254-62. PubMed ID: 15811142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of a 12-week low glycaemic index diet on heart disease risk factors and 24 h glycaemic response in healthy middle-aged volunteers at risk of heart disease: a pilot study.
    Philippou E; McGowan BM; Brynes AE; Dornhorst A; Leeds AR; Frost GS
    Eur J Clin Nutr; 2008 Jan; 62(1):145-9. PubMed ID: 17311054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can dietary magnesium modulate lipoprotein metabolism?
    Singh RB; Rastogi SS; Sharma VK; Saharia RB; Kulshretha SK
    Magnes Trace Elem; 1990; 9(5):255-64. PubMed ID: 2130823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of a weight-loss program on mental stress-induced cardiovascular responses and recovery.
    Torres SJ; Nowson CA
    Nutrition; 2007; 23(7-8):521-8. PubMed ID: 17560080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beneficial effect of low carbohydrate in low calorie diets on visceral fat reduction in type 2 diabetic patients with obesity.
    Miyashita Y; Koide N; Ohtsuka M; Ozaki H; Itoh Y; Oyama T; Uetake T; Ariga K; Shirai K
    Diabetes Res Clin Pract; 2004 Sep; 65(3):235-41. PubMed ID: 15331203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of weight loss on insulin sensitivity and cardiovascular risk factors in glucose tolerant and intolerant obese subjects.
    Calle-Pascual AL; Rodriguez C; Martin-Alvarez PJ; Camacho F; Calle JR; Yuste E; Hildago I; Diaz RJ; Martin-Vaquero P; Santiago M
    Diabete Metab; 1991; 17(4):404-9. PubMed ID: 1915998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oat-derived beta-glucan significantly improves HDLC and diminishes LDLC and non-HDL cholesterol in overweight individuals with mild hypercholesterolemia.
    Reyna-Villasmil N; Bermúdez-Pirela V; Mengual-Moreno E; Arias N; Cano-Ponce C; Leal-Gonzalez E; Souki A; Inglett GE; Israili ZH; Hernández-Hernández R; Valasco M; Arraiz N
    Am J Ther; 2007; 14(2):203-12. PubMed ID: 17414591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin reduces weight, centripetal obesity, insulin, leptin, and low-density lipoprotein cholesterol in nondiabetic, morbidly obese subjects with body mass index greater than 30.
    Glueck CJ; Fontaine RN; Wang P; Subbiah MT; Weber K; Illig E; Streicher P; Sieve-Smith L; Tracy TM; Lang JE; McCullough P
    Metabolism; 2001 Jul; 50(7):856-61. PubMed ID: 11436194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased basal levels of glucagon-like peptide-1 after weight loss in obese subjects.
    de Luis DA; Gonzalez Sagrado M; Conde R; Aller R; Izaola O
    Ann Nutr Metab; 2007; 51(2):134-8. PubMed ID: 17536190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of metabolic syndrome among Filipino adults aged 20 years and over.
    Tanchoco CC; Cruz AJ; Duante CA; Litonjua AD
    Asia Pac J Clin Nutr; 2003; 12(3):271-6. PubMed ID: 14505989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. X-PERT: weight reduction with orlistat in obese subjects receiving a mildly or moderately reduced-energy diet: early response to treatment predicts weight maintenance.
    Toplak H; Ziegler O; Keller U; Hamann A; Godin C; Wittert G; Zanella MT; Zúñiga-Guajardo S; Van Gaal L
    Diabetes Obes Metab; 2005 Nov; 7(6):699-708. PubMed ID: 16219013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The national cholesterol education program diet vs a diet lower in carbohydrates and higher in protein and monounsaturated fat: a randomized trial.
    Aude YW; Agatston AS; Lopez-Jimenez F; Lieberman EH; Marie Almon ; Hansen M; Rojas G; Lamas GA; Hennekens CH
    Arch Intern Med; 2004 Oct; 164(19):2141-6. PubMed ID: 15505128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoprotein responses to weight loss and weight maintenance in high-risk obese subjects.
    Ditschuneit HH; Frier HI; Flechtner-Mors M
    Eur J Clin Nutr; 2002 Mar; 56(3):264-70. PubMed ID: 11960302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.